- Unusual Adverse Event With Vandetanib in Metastatic Medullary Thyroid Cancer
[作者:Duplomb, S; Benoit, A; Mechtouff-Cimarelli, L; Cho, TH; Derbel, O; Peix, JL; de la Fouchardiere, C,期刊:Journal of clinical oncology, 页码:E21-E23 , 文章类型: Article,,卷期:2012年30-2]
-
- Prognostic Effect of Circulating Adiponectin in a Randomized 2 x 2 Trial of Low-Dose Tamoxifen and Fenretinide in Premenopausal Women at Risk for Breast Cancer
[作者:Macis, D; Gandini, S; Guerrieri-Gonzaga, A; Johansson, H; Magni, P; Ruscica, M; Lazzeroni, M; Serrano, D; Cazzaniga, M; Mora, S; Feroce, I; Pizzamiglio, M; Sandri, MT; Gulisano, M; Bonanni, B; DeCensi, A,期刊:Journal of clinical oncology, 页码:151-157 , 文章类型: Article,,卷期:2012年30-2]
- Purpose Adipokines are linked to obesity and insulin sensitivity and have recently been related to breast cancer risk and prognosis. We investigated the associations of plasma leptin and adiponectin with mammographic den...
- Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
[作者:Wells, SA; Robinson, BG; Gagel, RF; Dralle, H; Fagin, JA; Santoro, M; Baudin, E; Elisei, R; Jarzab, B; Vasselli, JR; Read, J; Langmuir, P; Ryan, AJ; Schlumberger, MJ,期刊:Journal of clinical oncology, 页码:134-141 , 文章类型: Article; Proceedings Paper,,卷期:2012年30-2]
- Purpose There is no effective therapy for patients with advanced medullary thyroid carcinoma (MTC). Vandetanib, a once-daily oral inhibitor of RET kinase, vascular endothelial growth factor receptor, and epidermal growth...
- Randomized Phase II/III Trial Assessing Gemcitabine/Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: EORTC Study 30986
[作者:De Santis, M; Bellmunt, J; Mead, G; Kerst, JM; Leahy, M; Maroto, P; Gil, T; Marreaud, S; Daugaard, G; Skoneczna, I; Collette, S; Lorent, J; de Wit, R; Sylvester, R,期刊:Journal of clinical oncology, 页码:191-199 , 文章类型: Article,,卷期:2012年30-2]
- Purpose This is the first randomized phase II/III trial comparing two carboplatin-based chemotherapy regimens in patients with urothelial cancer who are ineligible ("unfit") for cisplatin chemotherapy. Patients and Metho...
- Randomized Phase III Study of Surgery Alone or Surgery Plus Preoperative Cisplatin and Gemcitabine in Stages IB to IIIA Non-Small-Cell Lung Cancer
[作者:Scagliotti, GV; Pastorino, U; Vansteenkiste, JF; Spaggiari, L; Facciolo, F; Orlowski, TM; Maiorino, L; Hetzel, M; Leschinger, M; Visseren-Grul, C; Torri, V,期刊:Journal of clinical oncology, 页码:172-178 , 文章类型: Article; Proceedings Paper,,卷期:2012年30-2]
- Purpose This study aimed to determine whether three preoperative cycles of gemcitabine plus cisplatin followed by radical surgery provides a reduction in the risk of progression compared with surgery alone in patients wi...
- Cerebral Sinus Thrombosis and Leptomeningeal Carcinomatosis in a Patient With Ovarian Cancer
[作者:Li, HK; Harding, V; Williamson, R; Blagden, S; Gabra, H; Agarwal, R,期刊:Journal of clinical oncology, 页码:E19-E20 , 文章类型: Article,,卷期:2012年30-2]
-
- Influence of Race, Insurance, Socioeconomic Status, and Hospital Type on Receipt of Guideline-Concordant Adjuvant Systemic Therapy for Locoregional Breast Cancers
[作者:Wu, XC; Lund, MJ; Kimmick, GG; Richardson, LC; Sabatino, SA; Chen, VW; Fleming, ST; Morris, CR; Huang, B; Trentham-Dietz, A; Lipscomb, J,期刊:Journal of clinical oncology, 页码:142-150 , 文章类型: Article,,卷期:2012年30-2]
- Purpose For breast cancer, guidelines direct the delivery of adjuvant systemic therapy on the basis of lymph node status, histology, tumor size, grade, and hormonal receptor status. We explored how race/ethnicity, insura...
|